ArticleEuropean journal of nuclear medicine and molecular imaging2025
Distinct metabolic patterns of neuropsychiatric systemic lupus erythematosus on hierarchical cluster analysis.
Article in European journal of nuclear medicine and molecular imaging, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Integrative Transcriptomic Analysis Reveals Impaired Oligodendrocyte Maturation and Myelination Signature in the Hippocampus of a Murine Model of Neuropsychiatric Lupus.International journal of molecular sciences · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeNeuropsychiatric systemic lupus erythematosus (NPSLE) is the second leading cause of morbidity and mortality in systemic lupus erythematosus (SLE). The pathogenesis of NPSLE is poorly understood and diagnosis is difficult. Advances in neuroimaging show promise, but no patterns specific for the disease have emerged. The identification of such patterns may be facilitated by statistical techniques such as cluster analysis. MATERIALS AND
methodsFDG PET-CT scans of 46 patients confirmed with NPSLE were included. Median values of each brain region of the Brainnetome atlas were extracted after normalisation for global counts. Hierarchical clustering of patients was performed and demographic, clinical and laboratory characteristics of the clusters were compared.
resultsOur analysis revealed an optimal cluster number of two. Comparing imaging features of scans in patient cluster 1 (n = 23) and patient cluster 2 (n = 23), scans in the latter group demonstrated significantly higher metabolism in basal ganglia, thalami, medial temporal lobes and cerebellum and hypometabolism in the frontal, parietal, occipital and lateral temporal lobes. Patients in cluster 2 had higher SLEDAI-2 K disease activity scores and erythrocyte sedimentation rates, greater frequencies of psychosis, cerebrovascular accidents, and vasculitis as manifested by rash and mucosal ulcers, and higher rates of positive anti-dsDNA and anti-Smith antibodies, as well as higher anti-Smith antibody titres.
conclusionWe identified a subgroup of NPSLE patients with a distinct FDG uptake pattern, higher disease activity and higher incidence of certain clinical symptoms and laboratory findings. This metabolic pattern is similar to that described in autoimmune encephalitis and may be driven by a common pathological mechanism.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.